EGFR and cancer: Our observation that STAT3 is a direct transcriptional repressor of EGFR, which has not previously been reported, is consistent with the recent report of increased EGFR signaling following JAK-STAT inhibition38 and may have implications for strategies to develop STAT3 inhibitors for cancer therapy.